Ana Luisa Corona-Nakamura

Prof. Dr. Ana Luisa Corona-Nakamura

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 October 2005 in HIV Medicine
Verified
Journal Article
Open access
PDF file
MEMartha Escoto-Delgadillo
Martha Escoto-Delgadillo
EVEDUARDO VAZQUEZ VALLS
EDUARDO VAZQUEZ VALLS
MRM Ramírez‐Rodríguez
M Ramírez‐Rodríguez
ACAna Luisa Corona-Nakamura
Ana Luisa Corona-Nakamura
GAG Amaya‐Tapia
G Amaya‐Tapia
BTBlanca Miriam Torres-Mendoza
Blanca Miriam Torres-Mendoza
Objectives: To describe the prevalence of baseline drug‐resistance mutations, resistance to antiretroviral drugs, and the subsequent virological response to therapy in treatment‐naïve patients from Mexico with established HIV‐1 infection.Methods: Resistance testing was performed on plasma samples from antiretroviral‐naïve patients. Data on mutations associated with antiretroviral drug resistance were obtained using Stanford software (http://hivdb.stanford.edu).Results: Ninety‐six treatment‐naïve individuals were enrolled in the study during 2002–2003. Of these, 83 patients (86%) had at least one resistance mutation and 15 (16%) had drug resistance. At baseline, the mean plasma viral load was 299 834 HIV‐1 RNA copies/mL, and at follow‐up it was 37 620 copies/mL (P<0.0001). Primary mutations in the reverse transcriptase region were observed in 15% of patients. For nucleoside inhibitors, mutations T215Y/C and F77L (3%) and D67N/S, T69N and M184V (2%), were detected. For nonnucleoside inhibitors, mutations K103N/R (6%), Y181C (3%) and G190A (2%) were detected. Overall, 6% of patients showed resistance to delavirdine and nevirapine, 4% to efavirenz, and 2% to lamivudine and nelfinavir. Twelve patients showed no response to treatment and three of these patients had antiretroviral drug resistance.Conclusions: The prevalence of baseline drug‐resistance mutations found in this study was similar to that found in previous reports for newly HIV‐infected individuals, although access to and management of antiretrovirals in Mexico are different.

1 May 2001 in Archives of Medical Research
Verified
Journal Article
Closed access
ACAna Luisa Corona-Nakamura
Ana Luisa Corona-Nakamura
Guadalupe Miranda-NovalesGuadalupe Miranda-Novales
Guadalupe Miranda-Novales
BLBlanca Leaños-Miranda
Blanca Leaños-Miranda
LPLeopoldo Portillo-Gómez
Leopoldo Portillo-Gómez
AHAbel Hernández-Chávez
Abel Hernández-Chávez
SASergio Aguilar-Benavides
Sergio Aguilar-Benavides

16 June 2018 in World Journal of Clinical Cases
Verified
Journal Article
Open access
RARoberto Anaya-Prado
Roberto Anaya-Prado
JPJosé V Pérez-Navarro
José V Pérez-Navarro
ACAna Luisa Corona-Nakamura
Ana Luisa Corona-Nakamura
MAMichelle M Anaya-Fernández
Michelle M Anaya-Fernández
RARoberto Anaya-Fernández
Roberto Anaya-Fernández
MIMarian Eliza Izaguirre-Pérez
Marian Eliza Izaguirre-Pérez
Herpes zoster (HZ) infection occurs in approximately 10% to 30% of individuals. Visceral neuropathies secondary to HZ can cause cystitis and urinary retention. But colonic pseudo-obstruction can also occur. Peripheral neuropathy may reveal segmental motor paresis of either upper or lower limbs, the abdominal muscles or the diaphragm. We report the case of a 62-year-old male patient who presented with abdominal distention and cutaneous vesicular eruption on the left side of the abdominal wall. Plain X-rays and computed tomography scan showed distended small bowel. A diagnosis of intestinal pseudo-obstruction was made secondary to segmental paresis of the small intestine and visceral neuropathy. Conservative management was successful and the patient was discharged uneventfully. Intestinal pseudo-obstruction ought to be considered when dealing with non-obstructive (adynamic) conditions of the digestive tract associated with HZ infection; since early recognition may help to avoid unnecessary surgery.

1 July 2009 in Transplantation Proceedings
Verified
Journal Article
Closed access
ACAna Luisa Corona-Nakamura
Ana Luisa Corona-Nakamura
FMF.J. Monteón-Ramos
F.J. Monteón-Ramos
RTR. Troyo-Sanromán
R. Troyo-Sanromán
MAM.J. Arias-Merino
M.J. Arias-Merino
RAR. Anaya-Prado
R. Anaya-Prado

1 September 2005 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
GGGabriela Gonzalez
Gabriela Gonzalez
LEL.C. Escobedo-Zavala
L.C. Escobedo-Zavala
FMF. Carrillo de la Mora
F. Carrillo de la Mora
AOA. Ortiz-Arriaga
A. Ortiz-Arriaga
ACA. Cordero-Zamora
A. Cordero-Zamora
GRG.A. Velázquez Ramírez
G.A. Velázquez Ramírez

16 August 2013 in International Journal of Immunogenetics
Verified
Journal Article
Closed access
PDF file
GCG N López Campos
G N López Campos
JVJesús Salvador Velarde-Félix
Jesús Salvador Velarde-Félix
LRL Sandoval Ramírez
L Sandoval Ramírez
SSS Cázares Salazar
S Cázares Salazar
ACAna Luisa Corona-Nakamura
Ana Luisa Corona-Nakamura
EPErnesto Prado
Ernesto Prado